News | Science Selection Volume 122 | Issue 8 | August 2014
Environ Health Perspect; DOI:10.1289/ehp.122-A221
More Evidence for PBDEs as Neurotoxicants: Cohort Study Corroborates Earlier Findings
Kellyn S. Betts writes about environmental contaminants, hazards, and technology for solving environmental problems for publications including EHP and Environmental Science & Technology.
Citation: Betts KS. 2014. More evidence for PBDEs as neurotoxicants: cohort study corroborates earlier findings. Environ Health Perspect 122:A221; http://dx.doi.org/10.1289/ehp.122-A221
Published: 1 August 2014
Related EHP Article
Children from the Midwest involved in a prospective study are the third U.S. birth cohort to show strikingly consistent associations between prenatal exposure to polybrominated diphenyl ether (PBDE) flame retardants and impaired performance on neurodevelopment tests later in childhood.1 As in the earlier studies involving birth cohorts from New York City2 and California,3 the children’s mothers had PBDE levels consistent with average U.S. adult exposure. The concordance of the three studies strongly supports the likelihood that PBDEs are developmental neurotoxicants, according to the authors of the new work.
PBDEs were widely used between the 1970s and 2004 in U.S. consumer goods including furniture, carpet padding, and electronic devices. The main PBDEs found in humans are from the now-banned penta and octa mixtures used in polyurethane foam padding and electronics enclosures, respectively.4 People can accumulate PBDEs in their bodies through food and inadvertent ingestion, inhalation, and dermal absorption of house dust.5,6
The new research involved participants in the Health Outcomes and Measures of the Environment (HOME) Study, a prospective birth cohort of women living around Cincinnati, Ohio, who were pregnant between 2003 and 2006. All 309 mothers provided blood samples at about 16 weeks’ gestation, and all had detectable levels of BDE-47, one of the most commonly detected PBDE congeners and the focus of the new study’s primary analysis. Their children underwent yearly developmental and/or behavioral assessments through age 5, plus IQ testing at the last followup.
After adjusting for potential confounders, including maternal IQ, the researchers found a statistically significant inverse relationship between mothers’ BDE-47 concentrations and their children’s IQ scores, says coauthor Aimin Chen, an epidemiologist at the University of Cincinnati College of Medicine. In repeated measurements of cognition, a 10-fold increase in maternal BDE-47 concentration was associated with a 4.5-point reduction in IQ score,1 consistent with decrements reported for the New York City2 and California3 cohorts. Exposure was also associated with a 3.3-point increase in hyperactivity score.1
“What’s really important is the consistency in the results across three very different populations, [which is] pretty amazing,” says Linda Birnbaum, director of the National Institute of Environmental Health Sciences. She observes that the new study’s use of maternal serum taken during the first part of the second trimester—earlier than in the other cohorts—suggests outcomes could be linked to earlier in utero exposures.
Small shifts in a population’s IQ matter, says coauthor Bruce Lanphear of Simon Frasier University in Vancouver, Canada. Lanphear, who is the senior principal investigator of the HOME Study, explains that a 5-point shift downward in the mean IQ of U.S. children would result in an additional 3.4 million children who are considered intellectually disabled or mentally retarded,7 with corresponding costs in treatment, special education, and lost lifetime earnings. “There isn’t a published estimate of the cost of PBDE toxicity,” he says, “but based on what we know about the impact and costs of lead toxicity, I would expect the cost of PBDEs to exceed $10 billion annually in the United States.”
The prospective cohort design with repeated follow-up visits is a major strength of the new study. Its weaknesses include the lack of PBDE measurements in the children’s serum, which other research shows can be higher than maternal levels.3,8 Julie Herbstman of Columbia University’s Mailman School of Public Health, lead author of the earlier New York City study,2 also points out that the half-life of BDE-47 in humans is thought to be on the order of years, so it’s hard to isolate the timing of exposure.
There is some evidence that PBDE levels are declining in the U.S. population.9 Even so, “pretty much everyone still has penta- and octa-containing products in their home,” says Herbstman. Typically, the types of products that contained these compounds—such as couches—are not replaced frequently.
Because PBDEs’ persistence allows them to remain in indoor environments for a long time, Chen recommends that prospective mothers and other concerned individuals wash their hands frequently, vacuum with HEPA filters, and use wet cloths to dust furniture. The nonprofit Environmental Working Group also recommends replacing any foam-containing item with a ripped cover or cushioning that is misshapen or breaking down.10
1. Chen A, et al. Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U.S. children through 5 years of age: the HOME Study. Environ Health Perspect 122(8):856–862 (2014); doi: 10.1289/ehp.1307562.
2. Herbstman JB, et al. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect 118(5):712–719 (2010); doi: 10.1289/ehp.0901340.
3. Eskenazi B, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS Study. Environ Health Perspect 121(2):257–262 (2013); doi: 10.1289/ehp.1205597.
4. Geyer HJ, et al. Terminal elimination half-lives of the brominated flame retardants TBBPA, HBCD, and lower brominated PBDEs in humans. Organohalogen Comp 66:3867–3872 (2004). Available: http://www.dioxin20xx.org/ohc_database_search.htm [accessed 25 June 2014].
5. Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Environ Epidemiol 18(1):2–19 (2008); doi: 10.1038/sj.jes.7500572.
6. CDC. Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:U.S. Centers for Disease Control and Prevention (2009). Available: http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf [accessed 25 June 2014].
7. Gilbert SG, Weiss B. A rationale for lowering the blood lead action level from 10 to 2 μg/dL. Neurotoxicology 27(5):693–701 (2006); doi: 10.1016/j.neuro.2006.06.008.
8. Toms L-ML, et al. Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2–5 years of age) than in infants and adults. Environ Health Perspect 117(9):1461–1465 (2009); doi: 10.1289/ehp.0900596.
9. Zota AR, et al. Temporal comparison of PBDEs, OH-PBDEs, PCBs, and OH-PCBs in the serum of second trimester pregnant women recruited from San Francisco General Hospital, California. Environ Sci Technol 47(20):11776–11784 (2013); doi: 10.1021/es402204y.
10. EWG. Healthy Home Tips: Tip 4—Avoid Fire Retardants [website]. Washington, DC:Environmental Working Group (2014). Available: http://www.ewg.org/research/healthy-home-tips/tip-4-avoid-fire-retardants [accessed 25 June 2014].
CEHN August 2015 Article of the Month“Ambient Heat and Sudden Infant Death: A Case-Crossover Study Spanning 30 years in Montreal, Canada” (DOI:10.1289/ehp.1307960) has been selected by the Children’s Environmental Health Network (CEHN) as its August 2015 Article of the Month. These CEHN summaries discuss the potential policy implications of current children’s environmental health research.
Sign Up to Receive E-mail Alerts
Recent Advance Publications
Traffic-Related Air Pollution and Dementia Incidence in Northern Sweden: A Longitudinal Study
Multiple Trigger Points for Quantifying Heat-Health Impacts: New Evidence from a Hot Climate
Environmental Chemicals in Urine and Blood: Improving Methods for Creatinine and Lipid Adjustment
Satellite-Based Spatiotemporal Trends in PM2.5 Concentrations: China, 2004–2013
Desert Dust Outbreaks in Southern Europe: Contribution to Daily PM10 Concentrations and Short-Term Associations with Mortality and Hospital Admissions